What are the clinical uses of isoproterenol (isoprenaline)?

Isoproterenol Clinical Uses

Isoproterenol is primarily used as a second-line agent for symptomatic or hemodynamically unstable bradycardia (particularly sinus node dysfunction and atrioventricular block) when patients have low likelihood of coronary ischemia, and as an adjunctive agent in electrophysiology laboratories for arrhythmia provocation. 1

Primary Indications

1. Symptomatic Bradycardia (Second-Line Agent)

For patients with sinus node dysfunction (SND) or atrioventricular block causing symptoms or hemodynamic compromise, isoproterenol may be considered when atropine fails or is contraindicated, particularly in patients at low risk for coronary ischemia. 1

• Dosing: 20-60 mcg IV bolus followed by 10-20 mcg increments, or continuous infusion of 1-20 mcg/min (typically starting at 2-10 mcg/min) titrated to heart rate response 1, 2
• Pediatric dosing: 0.1-1 mcg/kg/min infusion 2
• Class IIb recommendation (may be considered) from ACC/AHA/HRS 2018 guidelines 1

Critical caveat: Isoproterenol increases myocardial oxygen demand through beta-1 effects while simultaneously decreasing coronary perfusion through beta-2 vasodilatory effects. It must be avoided in any setting where coronary ischemia is suspected. 1 Two RCTs showed no benefit for cardiac arrest resuscitation. 1

2. Electrophysiology Laboratory Applications

Isoproterenol is routinely used during electrophysiology studies to provoke and unmask arrhythmias, particularly supraventricular tachycardias. 3

• SVT induction: Isoproterenol successfully induces arrhythmias in 71% of cases during EPS, significantly better than epinephrine (53%, OR 2.35, P=0.021) 3
• Dosing for EPS: 1-20 mcg/min IV infusion 1
• HCM evaluation: Isoproterenol-guided transesophageal echocardiography can unmask latent left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients with poor transthoracic windows 4
• Syncope evaluation: Low-dose isoproterenol (2-5 mcg/min) during tilt-table testing improves sensitivity for vasovagal syncope diagnosis (85.7% vs 20.8% passive tilt) with acceptable specificity when doses remain <3 mcg/min 5

3. Dobutamine Stress Echocardiography Adjunct

Isoproterenol can be used as an adjunctive agent when target heart rate (85% of maximum predicted) is not achieved with dobutamine and atropine during stress echocardiography. 6

• Successfully achieved target heart rate in 64% of cases where dobutamine/atropine failed 6
• Similar safety profile to standard dobutamine stress testing 6
• Common side effects: premature ventricular contractions (39%), nausea/vomiting (17%), chest pain (6%) 6

4. Post-Heart Transplant Right Ventricular Failure

Emerging evidence supports isoproterenol for right ventricular failure after heart transplantation, where it improves right ventricle-pulmonary artery coupling and cardiac index. 7

• Increases cardiac index from 2.3 to 3.0 L/min/m² (P<0.001) 7
• Improves RV-PA coupling (RV ejection fraction/sPAP ratio increased from 0.8 to 1.0%·mmHg⁻¹, P=0.001) 7
• Dosing: 0.025-0.05 mcg/kg/min 7
• Rationale: Atropine is contraindicated post-transplant due to denervated hearts (causes paradoxical heart block in 20% of cases) 1

Contraindications (FDA Label)

Absolute contraindications 2:

• Pre-existing tachycardia
• Ventricular arrhythmias
• Angina pectoris

Critical Safety Considerations

Cardiac Risks

• May induce cardiac arrhythmias and myocardial ischemia, especially in patients with coronary artery disease or cardiomyopathy 2
• Monitor continuously with ECG during infusion 2

Drug Interactions

• Never administer simultaneously with epinephrine - combined direct cardiac stimulation may induce serious arrhythmias 2
• Effects potentiated by: tricyclic antidepressants, MAO inhibitors, levothyroxine, certain antihistamines (chlorpheniramine, tripelennamine, diphenhydramine) 2
• Effects antagonized by: beta-blockers (propranolol) 2

Obstetric Considerations

• Avoid during second stage of labor - may delay delivery 2
• Avoid when maternal BP >130/80 mmHg - risk of uterine vasoconstriction, decreased uterine blood flow, hemorrhage, and fetal anoxia 2

Pediatric Warning

In refractory asthmatic children, isoproterenol has caused clinical deterioration, myocardial necrosis, congestive heart failure, and death 2. While historical data from 1983 showed efficacy at low doses (mean 0.2 mcg/kg/min) for status asthmaticus 8, this indication has been largely abandoned due to cardiac toxicity risks, particularly with concurrent acidosis, hypoxemia, corticosteroids, or methylxanthines 2.

Practical Algorithm for Use

Step 1: Confirm symptomatic/hemodynamically unstable bradycardia Step 2: Rule out coronary ischemia (ECG, troponin, clinical assessment) Step 3: Attempt atropine first (0.5-1 mg IV, may repeat to 3 mg total) 1 Step 4: If atropine fails and low ischemia risk → Consider isoproterenol 2-10 mcg/min IV, titrate to effect 1, 2 Step 5: Continuous cardiac monitoring mandatory; measure cardiac enzymes if prolonged infusion 2